Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against bluebird bio, Inc. – BLUE
NEW YORK, February 22, 2021 (GLOBE NEWSWIRE) – Zhang Investor Law announces class action lawsuit on behalf of shareholders who will purchase shares of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020 have inclusive (the “Class Period”).
To participate in the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=bluebird-bio-inc&id=2586 or call Sophie Zhang, Esq. toll free at 800-991-3756 or email email@example.com for information about the class action.
If you would like to participate in this class action, please enter your details here. http://zhanginvestorlaw.com/join-action-form/?slug=bluebird-bio-inc&id=2586
If you want to appear as the lead plaintiff, you must go to court April 13, 2021 DEADLINE. A lead plaintiff is a representative party who acts on behalf of other class members in directing the dispute.
According to the lawsuit, throughout the classroom, defendants made false and / or misleading statements and / or failed to disclose this information that precludes Bluebird’s filing of the US Biologics Licensing Application (“BLA”) for LentiGlobin for Sickle Cell Disease (“SCD”) provide insufficient evidence to demonstrate the comparability of drugs; The defendants downplayed the foreseeable impact of disruptions related to the COVID-19 pandemic on the company’s BLA filing plan for LentiGlobin for SCD, particularly in relation to manufacturing. As a result of the foregoing, it was foreseeable that the company would not file the BLA for LentiGlobin for SCD in the second half of 2021. As a result, the company’s public statements have been materially false and misleading at all relevant times. When the real details hit the market, the lawsuit alleged that investors suffered damage.
Lead plaintiff status is not required to apply for compensation. You can keep an attorney of your choice. You can remain an absent class member and take no action at this point.
Zhang Investor Law represents investors worldwide. Lawyer advertising. Previous results do not guarantee similar results.
Zhang Investor Law PC
99 Wall Street, Suite 232
New York, New York 10005
Tel .: (800) 991-3756